Filter
447
Text search:
registered
pharmaceutical
product
Featured
Recommendations
38
New Publications
135
Language
Document type
No document type
266
Studies & Reports
66
Guidelines
61
Manuals
24
Strategic & Response Plan
13
Training Material
7
Fact sheets
5
Situation Updates
4
Resource Platforms
1
Countries / Regions
Kenya
24
Ethiopia
23
South Africa
19
Uganda
16
India
16
Nigeria
15
Liberia
14
Tanzania
14
Malawi
13
Zimbabwe
12
Sierra Leone
11
Ghana
11
Rwanda
11
Zambia
8
Western and Central Europe
8
Bangladesh
7
Namibia
7
Eswatini/ Swaziland
7
Nepal
6
Botswana
6
Global
6
Philippines
5
Lesotho
5
Cambodia
4
Indonesia
4
Ukraine
4
Myanmar / Burma
4
Senegal
3
Haiti
3
Syria
3
Eastern Europe
3
Albania
3
Sudan
2
Benin
2
North Macedonia
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
South Sudan
1
Jordan
1
Thailand
1
China
1
Ireland
1
Mozambique
1
Central African Republic
1
Libya
1
Angola
1
South–East Asia Region
1
Asia
1
Africa
1
Venezuela
1
Southern Africa
1
Russia
1
Bulgaria
1
Moldova
1
Iran
1
Australia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
20
Pharmacy & Technologies
18
Key Resources
13
Public Health
10
Capacity Building
5
Women & Child Health
5
Toolboxes
Pharmacy
64
AMR
42
TB
25
HIV
19
COVID-19
15
Mental Health
14
NTDs
8
Conflict
7
Global Health Education
5
Caregiver
5
Rapid Response
4
Disability
3
Planetary Health
3
Specific Hazards
2
Ebola
1
Cholera
1
Polio
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
Accessed November, 2017
PMPB/INS-GUIDE/01
Doc. No.: INS/GDL/001-(Annexes)
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
Accessed: 04.10.2019
The data collection process was organized by UCDC Director, Natalia Nizova, and M&E Department Head, Igor Kuzin, and implemented by M&E specialists from oblast AIDS Centers: Zhanna Antonenko, Oksana Gorbachuk, Volodymyr Zahorovskyi (Kiev City); Anna Lopatenko, Irina Kozina, I
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
Drug Distribution and Control: Preparation and Handling
This Technical Assistance Bulletin is intended to assist pharmacists in the extemporaneous compounding of non-sterile drug products for individual patients. Included in this document is information on facilities and equipment, ingredient
...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
